Department of Microbiology, Faculty of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran.
World J Pediatr. 2022 Sep;18(9):582-588. doi: 10.1007/s12519-022-00553-1. Epub 2022 Jun 4.
Coronavirus disease 2019 (COVID-19) has different manifestations in pediatric cases. It is assumed that they might present more gastrointestinal symptoms with a different viral shedding pattern in gastrointestinal samples. In this systematic review and meta-analysis, we aimed to evaluate the viral shedding pattern in gastrointestinal specimens of children with COVID-19.
We searched all published studies in English language in PubMed, Web of Science, and Scopus, up to date as of October 2021. Our search included the term "severe acute respiratory syndrome coronavirus 2, COVID-19, SARS-CoV-2, novel coronavirus, or coronavirus; and shed, excrete, secret, or carriage; and stool or rectal; and children or pediatrics". We included studies evaluating SARS-CoV-2 shedding in gastrointestinal specimens, including rectal swabs and stool samples of children with COVID-19 infection. We excluded duplicated data, case reports, and studies without original data.
Twelve studies met the eligibility criteria for the qualitative synthesis, 10 of which were included in the meta-analysis. The pooled prevalence of gastrointestinal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in children with COVID-19 was 86% (95% confidence interval 73%-96%, I = 62.28%). After respiratory specimen had become negative, 72% (43/60) had persistent shedding in gastrointestinal specimens. The gastrointestinal RNA had a positive test result for more than 70 days after symptoms onset.
Gastrointestinal shedding of SARS-CoV-2 might occur in a substantial portion of children and might persist long after negative respiratory testing. Further research is recommended to find the role of SARS-CoV-2 gastrointestinal shedding in transmission in children.
2019 年冠状病毒病(COVID-19)在儿科病例中有不同的表现。据推测,它们可能表现出更多的胃肠道症状,并在胃肠道样本中具有不同的病毒脱落模式。在本系统评价和荟萃分析中,我们旨在评估 COVID-19 患儿胃肠道标本中的病毒脱落模式。
我们在 PubMed、Web of Science 和 Scopus 中以英文搜索了截至 2021 年 10 月所有已发表的研究。我们的搜索包括以下术语:“严重急性呼吸综合征冠状病毒 2、COVID-19、SARS-CoV-2、新型冠状病毒或冠状病毒;和脱落、排泄、分泌或携带;和粪便或直肠;和儿童或儿科学”。我们纳入了评估 SARS-CoV-2 在胃肠道标本中脱落的研究,包括 COVID-19 感染儿童的直肠拭子和粪便样本。我们排除了重复数据、病例报告和没有原始数据的研究。
12 项研究符合定性综合的纳入标准,其中 10 项研究纳入荟萃分析。COVID-19 患儿胃肠道严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)RNA 的总体阳性率为 86%(95%置信区间 73%-96%,I=62.28%)。呼吸道标本转为阴性后,72%(43/60)的患儿胃肠道标本持续脱落。胃肠道 RNA 在症状出现后 70 天以上仍有阳性检测结果。
SARS-CoV-2 在胃肠道的脱落可能发生在相当一部分儿童中,并可能在呼吸道检测转为阴性后持续很长时间。建议进一步研究以确定 SARS-CoV-2 胃肠道脱落在儿童传播中的作用。